MMED is trading at $14.74 (4.1% down) in pre-market, pulling back from recent gains after a strong performance over the past two weeks.
- The move appears driven by profit-taking and sentiment-driven weakness as investors pivot to a risk-off stance ahead of the FOMC minutes release.
- No fresh company-specific headlines or major announcements have been reported to account for the downward pressure.
- Broader market indices and tech-related names are also trading lower, contributing to the negative momentum in the early session.